BackPortage Biotech Overview

Portage Biotech Current Cash

Track Portage Biotech's current cash ($1.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.67M
66.79% YoYΔ $-3.36M vs prior year quarter

Peer trimmed avg / median

Loading

Portage Biotech Current Cash History

Loading

Portage Biotech vs. peers: Current Cash Comparison

Loading

Portage Biotech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Portage Biotech (PRTG) FAQ

The latest current cash for PRTG is $1.7M as of March 2025. That compares with $5M in the prior-year period — down 66.8% year over year. Investors often review this figure alongside Portage Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRTG's current cash moved from $5M to $1.7M — a 66.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Portage Biotech's operating scale or balance-sheet position.

A current cash figure of $1.7M for PRTG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PRTG's current cash ($1.7M), review year-over-year change from $5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Portage Biotech's current cash against similar Energy names. You can also browse sector and industry screens on Stockcircle for a broader set of Energy companies and their key multiples and fundamentals.